MoneyWorks4Me

Bliss GVS Pharma submits disclosure of related party transactions

02 Dec 2019 Evaluate

Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bliss GVS Pharma has informed about submission of disclosure of related party transactions on the basis on consolidated financial statements for the half year ended September 30, 2019. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1857.30
Dr. Reddys Labs. 1149.10
Cipla 1355.95
Lupin 2052.30
Zydus Lifesciences 1107.95
View more..